BETHESDA, Md., Oct. 28, 2014 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today provided an update regarding Spherix v. VTech, Case No. 3:13-cv-03494-M and Spherix v. Uniden, Case No. 3:13-cv-03496-M, both in the United States District Court for the Northern District of Texas.

Spherix Logo.

On October 27, 2014 Donald Puckett, Skiermont Puckett, LLP co-founder, who has been recognized as a 2014 Texas Super Lawyer by Thomson Reuters and the publishers of Texas Monthly magazine, represented Spherix and presented the Technology Tutorial in a non-evidentiary presentation prepared for the educational benefit of the Court in preparation of the Markman hearing.  The next step in this case will be the Markman hearing which is scheduled for November 21, 2014.  Spherix continues its policy of open dialogue with all defendants and looks forward to continuing to present its case.

About Spherix
Spherix Incorporated was launched in 1967 as a scientific research company. Spherix is committed to advancing innovation by active participation in the patent market. Spherix draws on portfolios of pioneering technology patents to partner with and support product innovation.

Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Investor Relations:     
Hayden IR
Brett Mass, Managing Partner
Phone: (646) 536-7331
Email: brett@haydenir.com
www.haydenir.com

Spherix:                      
Phone: (703) 992-9325
Email: info@spherix.com
www.spherix.com

Logo - http://photos.prnewswire.com/prnh/20131104/PH08853LOGO  

SOURCE Spherix Incorporated

Copyright 2014 PR Newswire

Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Alkido Pharma Charts.
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Alkido Pharma Charts.